Oncology Clinical Trials in Miami, FL
As of September 2026, 270 paid clinical trials are recruiting for Oncology in Miami, Florida. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Miami
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
271 clinical trials for Oncology
·Clear filters·A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
A Phase 1/1b Study of IAM1363 in HER2 Cancers
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
Top Research Study Locations in Miami
Researchers run research studies in Miami, FL at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Miami | Multiple Myeloma, Prostate Cancer, Cancer | 264 |
| University of Miami Miller School of Medicine-Sylvester Cancer Center | Anatomic Stage IV Breast Cancer AJCC v8, Malignant Solid Neoplasm, Acute Myeloid Leukemia | 73 |
| Nicklaus Children's Hospital | Neuroblastoma, Malignant Solid Neoplasm, Osteosarcoma | 53 |
| Miami Cancer Institute | Acute Myeloid Leukemia, Brain Cancer, Breast Cancer | 40 |
| UM Sylvester Comprehensive Cancer Center at Kendall | Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Malignant Solid Neoplasm, Stage IV Lung Cancer AJCC v8 | 32 |
| Sylvester Comprehensive Cancer Center | Multiple Myeloma, Breast Cancer, Chronic Lymphocytic Leukemia | 29 |
| GSK Investigational Site | HIV Infections, Non-alcoholic Fatty Liver Disease, Pulmonary Disease, Chronic Obstructive | 24 |
| University of Miami Miller School of Medicine | Alopecia, Amyotrophic Lateral Sclerosis, Ann Arbor Stage I Diffuse Large B-Cell Lymphoma | 19 |
| Miami Cancer Institute at Baptist Health, Inc. | Breast Cancer, Cancer, Carcinoma, Non-Small-Cell Lung | 16 |
| Bascom Palmer Eye Institute | Stargardt Disease, Eye Diseases, Glaucoma | 16 |
| University of Miami Hospital and Clinics | Multiple Myeloma, Advanced Cancer, Advanced Colorectal Cancer (Part 1) | 16 |
| University of Miami Hospital | Anaplastic Astrocytoma, Coronary Artery Disease, Critical Illness | 14 |
| New Horizon Research Center | Obesity, Overweight, Chronic Pain | 12 |
| Florida International University | Electronic Cigarette Use, Hiv, Anxiety Symptoms | 10 |
| Jackson Memorial Hospital | Intracerebral Hemorrhage, Ischemic Stroke, Traumatic Brain Injury | 10 |
| University of Miami - Sylvester Comprehensive Cancer Center | Breast Cancer, Advanced Solid Tumor, Lung Cancer | 10 |
| University of Miami Health System | Aneurysm, Brain, Artificial Intelligence (AI), Blood Vessel Injury | 10 |
| Visionary Investigators Network | AChR-Ab Seropositive Generalized Myasthenia Gravis, gMG, Generalized Myasthenia Gravis | 9 |
| Miami VA Healthcare System, Miami, FL | Epilepsy, Atherosclerosis, Atrial Fibrillation | 9 |
| Baptist Health South Florida | Heart Failure, Aneurysmal Subarachnoid Hemorrhage (aSAH), Breast Cancer | 8 |
| University of Miami Sylvester Comprehensive Cancer Center | Acute Myeloid Leukemia, Advanced Solid Tumors, Bone Marrow Transplant Complications | 8 |
| Bioresearch Partner | Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma, Bacterial Infections | 7 |
| Entrust Clinical Research | Clostridoides Difficile Associated Disease, Hypercholesterolaemia, Hypertension (HTN) | 7 |
| South Florida Research Phase I-IV | Agitation Associated With Alzheimer's Dementia, Alzheimer Disease, Bipolar Disorder | 7 |
| Neurocrine Clinical Site | Major Depressive Disorder, Schizophrenia, Tardive Dyskinesia | 6 |
Active & Upcoming Studies in Miami (2026)
Recruiting trials in Miami grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (377 active studies)
- Intralesional Chemotherapy (IC): Cisplatin + Epinephrine · Phase 2 · University of Miami
- Signatera Assessment in Early-Stage Endometrial Cancer · Natera, Inc.
Neurology & pain (95 active studies)
- CnF-DBS for Levodopa-Resistant FOG · Iahn Cajigas
- Dose Dependent Steroid Injections · Phase 4 · University of Miami
Diabetes & metabolic (71 active studies)
- PLAY2CONTROL Study · University of Miami
- Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study · Endogenex, Inc.
Cardiovascular (50 active studies)
- A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF · Phase 3 · AstraZeneca
- BOdygUardian MOnitoriNg for ReCurrencE of AF · Heart Rhythm Clinical and Research Solutions, LLC
Mental health & behavior (43 active studies)
- Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study · Duke University
HIV / STI (29 active studies)
- PrEP & Soccer: A Program for Pharmacy Chains to Increase PrEP Awareness and Access Among Men · University of Miami
- BRIDGES: An HIV Doula Program · University of Miami
Vaccines (10 active studies)
- A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease · Phase 3 · Shionogi
- A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age · Phase 3 · GlaxoSmithKline
Eye & vision (10 active studies)
- Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye · Phase 2 · University of Miami
- A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration · Phase 3 · Amgen
Pediatric (8 active studies)
- Artificially Intelligent Robot Control · University of Miami
- CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) · Phase 1, Phase 2 · COUR Pharmaceutical Development Company, Inc.
Common conditions studied in Miami
- Breast Cancer (32 active studies)
- Obesity (23 active studies)
- Prostate Cancer (20 active studies)
- Overweight (18 active studies)
- Ulcerative Colitis (17 active studies)
- Alzheimer Disease (16 active studies)
Leading research sponsors in Miami
- University of Miami
- Eli Lilly and Company
- National Cancer Institute (NCI)
- Pfizer
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Miami?
There are approximately 1,358 recruiting clinical trials in Miami, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Miami pay participants?
Most recruiting trials in Miami compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Miami?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Miami?
The most common conditions under active study in Miami include Breast Cancer (32), Obesity (23), Prostate Cancer (20), Overweight (18), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Miami?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Miami on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Miami?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Miami?
Recruiting research sites in Miami include University of Miami, University of Miami Miller School of Medicine-Sylvester Cancer Center, Nicklaus Children's Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Miami right now?
The largest active categories in Miami are Cancer & tumors (377), Neurology & pain (95), Diabetes & metabolic (71). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.